Alzheimer’s: South Korean biotech AriBio reports its oral drug AR1001 slowed clinical decline by 31% in a prespecified group of Phase 3 participants taking it alone. The benefit was not significant across the full study population. Child Health: A Korean study found age- and sex-specific patterns linking childhood exposure to BPA and phthalates with liver enzyme levels in adolescence, but the overall associations were not statistically significant. Mercury Monitoring: Research involving 2,329 Korean children and teens suggests urine tests may help track seafood-related mercury exposure, offering a practical option when blood samples are difficult to collect. Food Safety: Seoul has pulled chili powder after pesticide levels were found at four times the legal limit. Care for the Underserved: Holy Family Welfare Hospital in Seoul, which provides free care and relies on donations and volunteers, has treated about 1.5 million people unable to afford medical treatment over 36 years.
AGP Executive Report
Your go-to archive of top headlines, summarized for quick and easy reading.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Alzheimer’s Research: South Korean biotech AriBio says its Phase 3 trial found daily pill AR1001 slowed cognitive and functional decline by 31% over a year among patients not taking other Alzheimer’s drugs. The result was not statistically significant in the broader group using other treatments. Fertility Care: The government is weighing wider fertility-treatment support while consulting specialists on how repeated procedures affect women’s physical and mental health. Food Safety: A Korean study found acrylamide in scorched rice crust rose sharply with longer heating, reaching about 80 times the level measured after two minutes at eight minutes. Healthcare Access: Seoul’s Holy Family Welfare Hospital, which has provided free care to about 1.5 million people since 1990, received an award for its service to patients in need. Biopharma: Lotte Biologics secured its first commercial production contract for its Songdo facility, ahead of the plant’s planned completion next year. Active Living: Seoul’s new runport hub near the Han River offers equipment rentals, group runs, a gym and recovery facilities.
Korean Pharma: HK inno.N’s acid-reflux drug K-CAB won approval in Brazil for three conditions, opening a market estimated at $750 million. Alzheimer’s Research: Korean biotech AriBio’s oral drug AR1001 slowed symptom decline by 31% among trial participants not taking existing dementia drugs, but showed no clear benefit across the full Phase 3 group. Long-Term Treatment: Five-year data for lecanemab suggested continued treatment can help keep some people with early Alzheimer’s in earlier disease stages; the findings were presented at an international conference. Nutrition: Korean researchers say whole vegetables and fruit may offer more benefit than supplements, as just one in four South Korean adults meets the recommended daily intake. Care Technology: AI is being used to read heart rhythms in Korean ambulances, with reports pointing to faster treatment.
Emergency Care: AI systems reading heart rhythms in South Korean ambulances aim to shorten treatment times, while emergency rooms are turning patients away as delays mount. Medical Innovation: Samsung Medical Center has performed 109 robotic epilepsy surgeries. Maternal Health: Calls are growing for public postpartum centers to serve families the market leaves behind. Health Tourism: More foreign visitors are coming to South Korea for health screenings.
Medication Safety: South Korea’s drug regulator found 571 online posts illegally selling or brokering medicines as exam aids ahead of the college entrance test; 553 involved methylphenidate, an ADHD drug that can cause harm when misused. Weight-Loss Drugs: U.S. regulators have ordered GLP-1 medicines including Wegovy and Mounjaro to warn of a rare risk of potentially permanent vision loss. Meanwhile, Japanese clinics are advertising cheaper Mounjaro to Korean visitors after rules eased for bringing in prescribed medicines. Medical Tourism: South Korea recorded 65,228 foreign patients seeking health screenings last year, up 17%; one provider reported a further 44% increase in visits from January to November. Maternal Care: A new commentary calls for public postpartum centers in areas where private facilities are scarce, noting that 99 local districts had none as of late 2025. K-Bio: Incheon will host a Songdo investment fair on Nov. 19, bringing Korean biotech firms together with investors and overseas buyers.
Medical Tourism: South Korea treated 65,228 foreign patients for health screenings in 2025, up 17% year over year; one major provider reported a 44% rise in overseas patients through November as tourism topped 20 million visitors. Weight-Loss Drugs: Oral obesity pills are nearing the Korean market as global competition heats up. Meanwhile, easier rules for bringing prescribed medicines home are drawing Koreans to Japan for cheaper Mounjaro, with travelers allowed up to a three-month supply. Emergency Care: Reports of patients being turned away from emergency rooms point to shortages in staff and capacity. A new law requiring designated hospitals to accept seriously ill emergency patients takes effect next April. Mental Health: Major-hospital ERs recorded 28,983 treatments linked to suicide or self-harm in 2025, down from 35,170 the year before. But the suicide rate among teenagers rose to 8.6 per 100,000, its highest level since records began.
Medical Regulation: South Korea’s Supreme Court ruled that suspending a pediatrician for giving an infant a hepatitis B vaccine one day past its expiry was unlawful. The child had no side effects, and the doctor promptly notified the family and advised a repeat dose. Workplace Health: A Seoul court recognized a restaurant cook’s cardiac death as work-related after finding the worker averaged nearly 58 hours a week in the 12 weeks before dying. Food and Diabetes: A large Harvard study linked each extra three weekly servings of fruit juice to an 8% higher relative risk of type 2 diabetes; replacing juice with whole fruit was associated with lower risk. Sleep and Care: Nearly nine in 10 Koreans report sleep problems, but only 6% seek treatment, according to a recent report. Weight-Loss Drugs: South Korea is allowing travelers to bring in a limited supply of prescribed obesity drugs from abroad, while regulators are also weighing label changes for Wegovy over concerns about possible vision loss.
Medication Safety: South Korea is weighing stronger warning labels for Wegovy and similar GLP-1 drugs amid concerns about vision loss, while allowing travelers to bring in up to a three-month supply of prescribed weight-loss medication. Indoor Air: Incense burning can sharply raise fine-particle pollution. A Korean study recorded levels more than 100 times higher than those from scented candles. Sleep Health: Nearly nine in 10 Koreans report sleep problems, but only 6% seek treatment, highlighting a gap in care. Access to Care: A pregnant woman reportedly visited 34 hospitals over three hours and traveled 130 kilometers before receiving care in Seoul. Separately, the government is proposing a seven-day limit on initial telemedicine prescriptions. Rare-Disease Care: South Korea is overhauling rules to widen access to treatments for rare diseases.
Medical AI: SBC Medical has invested in Taiwan’s NeuroBrain Dynamics and secured priority sales rights in South Korea and Japan, aiming to bring AI tools for clinic revenue, records and staffing to its network and other providers. Joint Pain: Older adults should not dismiss persistent shoulder or knee pain and severe morning stiffness as normal aging, a Seoul rheumatologist warns; late-onset rheumatoid arthritis and polymyalgia rheumatica can be mistaken for more common joint problems. Sleep Health: A survey of 500 Korean adults found 89% had experienced sleep problems in the past month, but only 6% sought treatment. Eight in 10 slept under seven hours, with many reporting fatigue, poor concentration and mood changes. Drug Safety: South Korea has flagged possible optic-nerve risks from GLP-1 weight-loss drugs, as the US FDA also requires a vision-loss warning. Biotech Policy: Korean officials have pledged faster drug approvals and more R&D support, while industry leaders call for shared cell-therapy manufacturing and stronger links from research to production.
Sleep Health: Nearly 9 in 10 South Koreans surveyed reported sleep problems in the past month, but only 6% sought treatment. Night waking was the most common complaint, and 80% slept fewer than seven hours a day. Support for At-Risk Households: From January, local officials can provide 300,000 won in emergency aid immediately to households facing urgent hardship, including those unable to afford infant formula or diapers. Medical Safety: A woman accused of attacking a psychiatrist at Seoul’s Severance Hospital has been referred to prosecutors on attempted-murder and other charges, renewing concern over violence against healthcare workers. Medical Devices: Samsung Medison opened a 50-billion-won ultrasound plant in Gangwon, aiming to double production capacity by 2030. Weight-Loss Drugs: New rules allow travelers to bring in up to six containers of medicines prescribed and bought abroad for personal use, prompting some Koreans to compare the cost of Mounjaro in Japan with local prices.
Hospital Safety: A woman was referred to prosecutors on attempted-murder charges after a knife attack injured a psychiatrist at Seoul’s Severance Hospital, highlighting the risks medical staff face and the disruption violence causes to patient care. Workplace Wellness: More Korean employers are investing in ongoing employee health support following new disclosure rules. Kakao Healthcare says its monitoring and coaching service now reaches about 100 companies and 40 public agencies. Obesity Medicines: South Korea has eased rules for travelers bringing in prescribed weight-loss drugs, while officials consider label changes for Wegovy amid concerns about vision risks. Health Access: The government has launched an online system connecting public medical institutions, and Seoul will let people with developmental disabilities plan future care in advance. Biotech Policy: Korea has pledged faster drug approvals and more R&D support, as industry forums call for shared cell-therapy manufacturing and stronger links from research labs to production.
Weight-Loss Drugs: South Korea now allows travelers to bring in up to a three-month supply of prescribed medicines bought abroad. The change has sparked a rush to Japan for cheaper Mounjaro: all 384 appointment slots on one Korean-language telemedicine platform were booked. Cardiac Care: Asian patients remain underrepresented in major cardiovascular, diabetes and obesity trials, making up 7.7% of participants despite accounting for nearly 60% of the world’s population. A Korean study cited by a regional heart specialist found potent antiplatelet drugs may carry greater bleeding risks for Asian patients. Biotech and Cell Therapy: At a Seoul forum, government officials pledged more biotech R&D support and regulatory improvements. Speakers called for shared cell-therapy manufacturing and quality-control facilities to help promising treatments reach patients. Medical AI: Lunit reported record nine-month revenue of 68 billion won, up 20% year on year, with overseas sales making up 95% of the total.
Emergency Care: A pregnant woman with pain and bleeding was taken 130 kilometers to Seoul after 34 hospitals could not accept her; nearly three hours passed before she reached care, renewing concerns about access to high-risk maternity services. Weight-Loss Drugs: South Korea will let travelers bring in up to a three-month supply of prescribed obesity drugs bought abroad. Separately, authorities are weighing label changes after reports linked GLP-1 drugs to optic nerve problems. Reproductive Health: The government is considering a certification route for non-OB-GYN doctors to prescribe abortion pills, planned for introduction in early 2027. Wellness Trends: Younger Koreans are spending less on late-night drinking and more on exercise, healthy food and recovery activities such as saunas.
Weight-Loss Drugs: From Nov. 12, travelers may bring in up to a three-month supply of medicines such as Wegovy and Mounjaro for personal treatment, if prescribed or purchased through a legitimate medical system. Separately, South Korea is reviewing safety-label changes for GLP-1 drugs after warnings of possible optic-nerve damage and vision loss. Public Healthcare: A new online system will connect public hospitals and extend AI-supported care to rural areas. It will be piloted at eight institutions this year, with expansion planned to 72 by 2029. Smoking: A medical expert has proposed nearly doubling cigarette prices, from 4,500 won to 8,500 won, to curb smoking. The Health Ministry favors other measures, keeping the tax debate open. Bird Flu: Recent outbreaks prompted the culling of more than 300,000 birds in South Korea, as authorities reported a case near the North Korean border.
Smart Hospitals: Daewoong Pharmaceutical unveiled an AI hospital model in Seoul, combining real-time patient monitoring, AI-supported diagnostics and robotic rehabilitation with a partner hospital’s smart-ward experience. Workplace Health: South Korea’s Supreme Court ordered a fresh review of benefits for the family of a hotel worker who died of a brain hemorrhage after years of rotating shifts, saying courts cannot dismiss a work-related link solely because hours fall below a ministry threshold. Smoking Policy: Experts are urging the government to nearly double cigarette prices to 8,500 won, arguing higher costs could help curb smoking. Heart Care: A Korean three-year trial found that starting patients on a statin plus ezetimibe did not outperform statin treatment alone. Obesity: A recent survey found about half of South Korean men in their 30s and 40s are classified as obese, highlighting a major prevention challenge.
Medical Misconduct: Seoul police referred 58 people, including nine doctors, over a kickback scheme that allegedly steered 802 patients to Gangnam clinics; doctors’ suspensions for kickbacks also rose sharply in the first half of the year. Medication Safety: The U.S. FDA ordered warning labels on GLP-1 drugs including Wegovy and Mounjaro for a rare optic-nerve condition that can cause permanent vision loss, advising patients with sudden vision changes to seek prompt care. Heart Health: A Korean trial found starting patients on a statin plus ezetimibe did not reduce major heart events more than starting with a statin alone; researchers said the LDL target mattered more than the initial drug combination. Digital Health: A South Korean study found smartwatch ECGs could flag weak heart pumping, but Apple and Samsung watches gave conflicting results for 9% of patients tested on both. Obesity: A recent survey found more than half of Korean men in their 30s and 40s are classified as obese.
Cancer Research: A Seoul-led preclinical study reports that an experimental drug cleared aggressive pancreatic tumors in mice and boosted immune memory. The findings are promising, but the treatment has not been shown to work in people. Drug Safety: FDA warning letters to Korean drug-manufacturing sites rose from three in 2020 to nine in 2024, with serious manufacturing violations raising risks of U.S. export restrictions and approval delays. Women’s Health: Femtech leaders called for better access to investment and sales channels, plus an official industry classification, to help Korea’s women’s-health technology sector grow. Obesity: Recent survey findings show more than half of Korean men in their 30s and 40s are obese, underscoring a major prevention challenge. Disease Watch: South Korea reported an H5N9 bird-flu outbreak at a Gyeonggi farm; the coverage did not report human infections.
Avian Flu: South Korea reported highly pathogenic H5N9 at a Gyeonggi poultry farm, where all 90,986 birds were culled. Obesity: About half of Korean men in their 30s and 40s are classified as obese, renewing concern over a major health risk. Women’s Health: Korea’s femtech market faces a support gap even as the global sector is forecast to grow more than 18% annually; this year brought the country’s first industry survey. Military Care: An audit found telemedicine reaches only 26% of remote military units, while some bases lack basic painkillers. Child Health: A 300-billion-won family donation has helped diagnose 22,646 children with cancer or rare diseases and provide treatment to 14,757 since 2021.
Cancer Care: Samsung Bioepis will provide its costly Keytruda biosimilar free to Phase 3 trial participants after the study ends, helping them complete the recommended treatment course. Stroke Treatment: Seoul-based Enventric plans to seek U.S. approval next year for its devices to remove clots from blocked brain vessels. Mental Health: A South Korean pilot trial found both mentalization-based therapy and structured clinical management reduced suicide attempts among people with borderline personality disorder; benefits from the first approach appeared more sustained in some areas. Nutrition: A survey shows South Koreans’ daily energy intake has fallen 11% in a decade, even as fat makes up a larger share of their diets. Women’s Health: A study linked sugary processed-food consumption with a 28% higher breast cancer risk among Korean women. Hospital Safety: Doctors are demanding stronger protections after a psychiatrist was stabbed at Seoul’s Severance Hospital.
Diet Trends: South Koreans’ average daily calorie intake fell about 11% over a decade, while fat made up a larger share of diets and carbohydrates less, KDCA data show. More people also fell below recommended calorie levels. Health Retail: Seoul’s “beauty pharmacies” are multiplying as foreign visitors seek skincare products; pharmacy spending by tourists nearly tripled year over year from January to September. Hospital Safety: A court approved the arrest of a woman accused of stabbing a psychiatrist at Severance Hospital, renewing concerns about protections for medical staff. Infection Watch: Flu infections have risen for a second straight week, signaling a rebound. Cancer Research: A study linked sugary processed foods with a 28% higher breast cancer risk among Korean women; the finding points to an association, not proof of cause.
Sign up for:
Health Daily South Korea
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.